BioLASCO Taiwan Co., Ltd.
6662
Rank in Stocks
#26076
BioLASCO Taiwan Co., Ltd., established in Taipei in 1990, operates as an... BioLASCO Taiwan Co., Ltd., established in Taipei in 1990, operates as an international supplier of bio-materials and surgical support services. The company specializes in breeding and producing Specific Pathogen-Free (SPF) laboratory rodents, encompassing various outbreed stocks, inbreed strains, and immune-deficient models, alongside providing bespoke animal model services. Its product portfolio extends to critical diagnostic and research tools, including kits for endotoxin detection, animal health diagnostics, and serological analysis, as well as biological indicators. Furthermore, BioLASCO furnishes a comprehensive array of laboratory equipment vital for animal research and facility management. This sophisticated equipment includes Individually Ventilated Cage (IVC) systems and ventilated housing units, professional automated animal watering systems, transponders, chlorine dioxide gas generators, and specialized devices such as mouse and rat tail cuff blood pressure systems, analgesia equipment, animal behavioral systems, metabolism and behavior tracking systems. The company also offers XPERT cabinet X-ray systems, automatic cleaning equipment, laboratory workstations, isolation chambers, and foggers.
Share Price
$0.86575863
Last synced: 2026-11-10
Market Cap
$22.17M
Change (1 day)
1.43%
Change (1 year)
-14.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioLASCO Taiwan Co., Ltd. (6662)
Category
Healthcare
EPS for BioLASCO Taiwan Co., Ltd. (6662)
EPS as of June 2026 TTM: $0.05
According to BioLASCO Taiwan Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of $0.05, equal to its 2024 EPS of $0.05.
EPS history for BioLASCO Taiwan Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.05 | -1.20% |
| 2025 | $0.05 | 0.95% |
| 2024 | $0.05 | -17.09% |
| 2023 | $0.06 | 17.47% |
| 2022 | $0.05 | -15.28% |
| 2021 | $0.06 | -27.18% |
| 2020 | $0.09 | 19.13% |
| 2019 | $0.07 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 31,600.40% |
US
|
|
| $-7.07 | -14,411.74% |
US
|
|
| $-5.29 | -10,808.50% |
AU
|
|
| $12.88 | 25,973.08% |
BE
|
|
| $21.56 | 43,543.72% |
NL
|
Questions about BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS)
What is BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS)?
BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.05, as of Jun 2026.
What was BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS) was $0.05, about the same as in 2024 ($0.05).
How has BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS) went from $0.09 to $0.05, an average decline of 11.09% a year.
How does BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS) compare with similar companies?
BioLASCO Taiwan Co., Ltd.'s earnings per share (EPS) ($0.05) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.